103 related articles for article (PubMed ID: 15266962)
1. Differential effect of cyclooxygenase-2 preferring [correction of prefering] inhibitors on electrically- and chemically-induced seizures in mice.
Reeta Kh; Mediratta PK; Mahajan P; Sharma KK
Indian J Physiol Pharmacol; 2003 Oct; 47(4):471-5. PubMed ID: 15266962
[No Abstract] [Full Text] [Related]
2. COX-2 and COX-2 enzyme inhibition.
Conti P
Int J Immunopathol Pharmacol; 2003; 16(2 Suppl):I-II. PubMed ID: 14552697
[No Abstract] [Full Text] [Related]
3. Medicine. Estrogen's ties to COX-2 may explain heart disease gender gap.
Couzin J
Science; 2004 Nov; 306(5700):1277. PubMed ID: 15550635
[No Abstract] [Full Text] [Related]
4. Role of cyclooxygenase-2 in lipopolysaccharide-induced hyperalgesia in formalin test.
Padi SS; Kulkarni SK
Indian J Exp Biol; 2005 Jan; 43(1):53-60. PubMed ID: 15691066
[TBL] [Abstract][Full Text] [Related]
5. Role of prostaglandin synthesis inhibitors on chemically induced seizures.
Bhaduri J; Hota D; Acharya SB
Indian J Exp Biol; 1995 Sep; 33(9):677-81. PubMed ID: 8557311
[TBL] [Abstract][Full Text] [Related]
6. COX-2 inhibitors and breast cancer.
Singh Ranger G; Mokbel K
ANZ J Surg; 2003 Aug; 73(8):565-6. PubMed ID: 12887516
[No Abstract] [Full Text] [Related]
7. Effect of cyclooxygenase-2 (COX-2) inhibitors in various animal models (bicuculline, picrotoxin, maximal electroshock-induced convulsions) of epilepsy with possible mechanism of action.
Dhir A; Naidu PS; Kulkarni SK
Indian J Exp Biol; 2006 Apr; 44(4):286-91. PubMed ID: 16629370
[TBL] [Abstract][Full Text] [Related]
8. [Cyclooxygenase 2 inhibitors and cancer chemoprevention].
Masmoudi A; Le Chevalier T; Sabatier L; Soria JC
Bull Cancer; 2004 May; 91 Spec No():S77-84. PubMed ID: 15239334
[TBL] [Abstract][Full Text] [Related]
9. [Progress in the study of cyclooxygenase].
Zhu H; Yang ZM
Sheng Li Ke Xue Jin Zhan; 2004 Jan; 35(1):81-3. PubMed ID: 15127608
[No Abstract] [Full Text] [Related]
10. Means, responders, and meaning: evaluation of clinical trials in osteoarthritis.
Schnitzer TJ
Arthritis Rheum; 2003 Nov; 48(11):3001-3. PubMed ID: 14613258
[No Abstract] [Full Text] [Related]
11. The potential danger of COX-2 inhibitors.
Norman RJ; Wu R
Fertil Steril; 2004 Mar; 81(3):493-4. PubMed ID: 15037388
[TBL] [Abstract][Full Text] [Related]
12. [Assessing the coxibs].
Paakkari I
Duodecim; 2003; 119(21):2071-7. PubMed ID: 14655538
[No Abstract] [Full Text] [Related]
13. [Cyclooxygenase 2 inhibitors and urologic and gynaecologic cancers].
Eschwege P
Bull Cancer; 2004 May; 91 Spec No():S113-6. PubMed ID: 15239339
[TBL] [Abstract][Full Text] [Related]
14. [Prostate carcinoma: higher COX-2 contents in advanced tumors].
Weiss J; Friedrich MG
Aktuelle Urol; 2004 Sep; 35(5):359-61. PubMed ID: 15383996
[No Abstract] [Full Text] [Related]
15. Effect of cyclooxygenase inhibitors on pentylenetetrazol (PTZ)-induced convulsions: Possible mechanism of action.
Dhir A; Naidu PS; Kulkarni SK
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Dec; 30(8):1478-85. PubMed ID: 16844276
[TBL] [Abstract][Full Text] [Related]
16. Design and synthesis of (E)-1,1,2-triarylethenes: novel inhibitors of the cyclooxygenase-2 (COX-2) isozyme.
Uddin MJ; Rao PN; McDonald R; Knaus EE
Bioorg Med Chem Lett; 2005 Jan; 15(2):439-42. PubMed ID: 15603969
[TBL] [Abstract][Full Text] [Related]
17. Pain from myelofibrosis treated with regular pamidronate.
Perkins P; Curtin NJ; Green AR; Booth S
Br J Haematol; 2004 Nov; 127(3):366-7. PubMed ID: 15491303
[No Abstract] [Full Text] [Related]
18. Reduced sulfur mustard-induced skin toxicity in cyclooxygenase-2 knockout and celecoxib-treated mice.
Wormser U; Langenbach R; Peddada S; Sintov A; Brodsky B; Nyska A
Toxicol Appl Pharmacol; 2004 Oct; 200(1):40-7. PubMed ID: 15451306
[TBL] [Abstract][Full Text] [Related]
19. Cyclooxygenase 2-dependent regulation of antitumor immunity in lung cancer.
Sharma S; Huang M; Dohadwala M; Pold M; Batra RK; Dubinett SM
Methods Mol Med; 2003; 75():723-36. PubMed ID: 12407775
[No Abstract] [Full Text] [Related]
20. [Cyclooxygenase-2-expression in bladder cancer: tumor-biological and clinical implications].
Wülfing C; Eltze E; Von Struensee D; Wülfing P; Bode ME; Bettendorf O; Piechota H; Hertle L
Aktuelle Urol; 2004 Aug; 35(4):331-8. PubMed ID: 15459875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
